Skip to main content

CDC: 22 States Have an Adult Obesity Prevalence ≥35 Percent

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Sept. 27, 2023 -- Twenty-two states have an adult obesity prevalence at or above 35 percent, up from 2021, according to data recently released by the U.S. Centers for Disease Control and Prevention.

State-based adult obesity prevalence was calculated by race, ethnicity, and location based on self-reported height and weight data from the Behavioral Risk Factor Surveillance System.

The 22 states with an adult obesity prevalence ≥35 percent include Alabama, Arkansas, Delaware, Georgia, Indiana, Iowa, Kansas, Kentucky, Louisiana, Mississippi, Missouri, Nebraska, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Tennessee, Texas, Virginia, West Virginia, and Wisconsin. In 2021, only 19 states had an adult obesity prevalence ≥35 percent, and 10 years ago, no state had an adult obesity prevalence ≥35 percent. The researchers observed differences in obesity prevalence by race and ethnicity, with American Indian or Alaska Native adults having a prevalence of 33 percent, Black adults 38 percent, Hispanic adults 32 percent, and White adults 14 percent.

"Our updated maps send a clear message that additional support for obesity prevention and treatment is an urgent priority," Karen Hacker, M.D., director of the CDC National Center for Chronic Disease Prevention and Health Promotion, said in a statement. "However, we know the key strategies that work include addressing the underlying social determinants of health such as access to health care, healthy and affordable food, and safe places for physical activity."

More Information

2022 Adult Obesity Prevalence Maps

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.